Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

P. Zufferey; S. Laporte; S. Molliex; C. Auboyer; P. Mismetti

doi:10.1111/j.1538-7836.2005.01318.x

Journal articles

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

P. Zufferey ¹ S. Laporte ¹ S. Molliex C. Auboyer P. Mismetti ¹

1 GRT (EA 3065) - Groupe de recherche sur la thrombose

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Pharmaceutical sciences / Pharmacology

Complete list of metadata

https://hal-ujm.archives-ouvertes.fr/ujm-00439804
Contributor : Patrick Mismetti Connect in order to contact the contributor
Submitted on : Tuesday, December 8, 2009 - 3:38:17 PM
Last modification on : Wednesday, November 20, 2019 - 2:33:05 AM

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

Links full text

Identifiers

Collections

Citation

Export

Metrics

Ximelagatran and melagatran vs. low-molecular-weight heparin in major orthopedic surgery: relationship between efficacy and safety and timing of initial administration.

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics